Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayse Erden

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Ovarian Research|January 20, 2026
Additive value of whole abdomen FDG PET/MRI to standard whole body PET/CT for detection of peritoneal recurrence of ovarian cancerMuhammet Halil Baltacioglu, Cigdem Soydal, Mine Araz, et al.
Nuclear Medicine Communications|January 11, 2023
Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective studyPinar Akkus Gunduz, Elgin Ozkan, Digdem Kuru Oz, et al.
European Radiology|November 21, 2023
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography aloneSerkan Duman, Digdem Kuru, Mesut Gumussoy, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2023
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analysesNabil Noureddin, Veeral Ajmera, Jaclyn Bergstrom, et al.
Hepatology (Baltimore, Md.)|May 19, 2023
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort studyBeom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2024
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver diseaseNabil Noureddin, Daniel Q Huang, Ricki Bettencourt, et al.
Gastroenterology|July 5, 2022
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual ParticipantsVeeral Ajmera, Beom Kyung Kim, Kun Yang, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2023
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortalitySung Won Lee, Daniel Q Huang, Ricki Bettencourt, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Ovarian Research|January 20, 2026
Additive value of whole abdomen FDG PET/MRI to standard whole body PET/CT for detection of peritoneal recurrence of ovarian cancerMuhammet Halil Baltacioglu, Cigdem Soydal, Mine Araz, et al.
Nuclear Medicine Communications|January 11, 2023
Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective studyPinar Akkus Gunduz, Elgin Ozkan, Digdem Kuru Oz, et al.
European Radiology|November 21, 2023
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography aloneSerkan Duman, Digdem Kuru, Mesut Gumussoy, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2023
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analysesNabil Noureddin, Veeral Ajmera, Jaclyn Bergstrom, et al.
Hepatology (Baltimore, Md.)|May 19, 2023
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort studyBeom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2024
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver diseaseNabil Noureddin, Daniel Q Huang, Ricki Bettencourt, et al.
Gastroenterology|July 5, 2022
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual ParticipantsVeeral Ajmera, Beom Kyung Kim, Kun Yang, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2023
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortalitySung Won Lee, Daniel Q Huang, Ricki Bettencourt, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
Pageof 3